Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The enterprise value (EV) is $3.94B.
ENTERPRISE VALUE (EV)
$3.94B
Relay Therapeutics, Inc.
Market Cap
$4.02B
Enterprise Value (EV)
$3.94B
| NAME | MARKET CAP | ENTERPRISE VALUE (EV) |
|---|---|---|
| Relay Therapeutics, Inc. (RLAY) | $4.02B | $3.94B |
| AbCellera Biologics Inc. (ABCL)vs › | $4.02B | $4.04B |
| ICU Medical, Inc. (ICUI)vs › | $3.97B | $4.95B |
| LivaNova PLC (LIVN)vs › | $4.14B | $3.98B |
| Regencell Bioscience Holdings Limited (RGC)vs › | $3.81B | $3.80B |
| Edgewise Therapeutics, Inc. (EWTX)vs › | $4.31B | $4.24B |
| Adaptive Biotechnologies Corporation (ADPT)vs › | $4.39B | $4.63B |
| Indivior Pharmaceuticals Inc (INDV)vs › | $4.43B | $4.72B |
| Heartflow, Inc. Common Stock (HTFL)vs › | $4.46B | $4.45B |
| iRhythm Technologies, Inc. (IRTC)vs › | $3.56B | $4.04B |
Market Cap
$4.02B
Total Debt
$0.00
Cash
$84.02M
Enterprise Value
$3.94B
Why use EV instead of Market Cap?
Enterprise Value represents the total value of a company as if you were to acquire it completely - paying for equity while assuming debt and receiving cash.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
